ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$5.43M |
| 2 |
Qualcomm
QCOM
|
+$4.78M |
| 3 |
Editas Medicine
EDIT
|
+$4.76M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$4.47M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$4.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$5.87M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$5.43M |
| 3 |
Netflix
NFLX
|
+$4.48M |
| 4 |
3D Systems Corp
DDD
|
+$3.58M |
| 5 |
NVIDIA
NVDA
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.09% |
| 2 | Healthcare | 20.07% |
| 3 | Communication Services | 14.97% |
| 4 | Industrials | 13.28% |
| 5 | Consumer Discretionary | 11.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Qualcomm
QCOM
$155B
| $5.17M | 1.49% |
90,121
+82,346
| +1,059% | +$4.78M |
|
|
27
Editas Medicine
EDIT
$396M
| $5.13M | 1.48% |
+229,922
| New | +$4.76M |
|
|
28
Ionis Pharmaceuticals
IONS
$8.6B
| $5.13M | 1.48% |
127,563
+120,942
| +1,827% | +$5.43M |
|
|
RHT
29
DELISTED
Red Hat Inc
RHT
| $5.11M | 1.47% |
59,068
+3,086
| +6% | +$245K |
|
30
Alibaba
BABA
$293B
| $5.04M | 1.45% |
46,768
+2,027
| +5% | +$206K |
|
|
XLNX
31
DELISTED
Xilinx Inc
XLNX
| $4.72M | 1.36% |
81,581
+73,600
| +922% | +$4.33M |
|
32
Trip.com Group
TCOM
$29.6B
| $4.66M | 1.34% |
94,887
+4,682
| +5% | +$215K |
|
|
XYZ
33
Block Inc
XYZ
$48.4B
| $4.22M | 1.22% |
244,000
+10,588
| +5% | +$166K |
|
34
Teradyne
TER
$57.6B
| $4.07M | 1.17% |
130,887
-36,851
| -22% | -$1.05M |
|
35
IBM
IBM
$211B
| $3.93M | 1.13% |
+23,613
| New | +$3.96M |
|
36
LendingTree
TREE
$447M
| $3.67M | 1.06% |
29,297
-4,875
| -14% | -$556K |
|
37
AeroVironment
AVAV
$7.56B
| $3.38M | 0.97% |
120,452
+263
| +0.2% | +$7.02K |
|
38
Cerus
CERS
$433M
| $3.3M | 0.95% |
742,278
+80,463
| +12% | +$341K |
|
39
Mercado Libre
MELI
$95.2B
| $3.27M | 0.94% |
15,486
-2,299
| -13% | -$450K |
|
40
Thermo Fisher Scientific
TMO
$213B
| $2.69M | 0.78% |
17,517
-213
| -1% | -$32.6K |
|
|
SCHW
41
Charles Schwab
SCHW
$183B
| $2.55M | 0.74% |
62,530
| – | – |
|
|
VIVS
42
VivoSim Labs
VIVS
$1.2M
| $1.96M | 0.57% |
2,568
+667
| +35% | +$528K |
|
|
MTLS
43
Materialise
MTLS
$368M
| $1.51M | 0.44% |
166,206
+33,309
| +25% | +$283K |
|
|
44
3D Systems Corp
DDD
$431M
| $1.26M | 0.36% |
84,015
-228,180
| -73% | -$3.58M |
|
45
Autodesk
ADSK
$49.5B
| $1.24M | 0.36% |
14,334
+2,556
| +22% | +$214K |
|
46
Compugen
CGEN
$222M
| $1.18M | 0.34% |
274,450
+53,600
| +24% | +$247K |
|
47
Intellia Therapeutics
NTLA
$1.49B
| $1.13M | 0.32% |
79,850
+53,306
| +201% | +$715K |
|
48
Trimble
TRMB
$13.2B
| $1.12M | 0.32% |
35,105
+3,143
| +10% | +$97.2K |
|
49
HP
HPQ
$24.9B
| $1.02M | 0.29% |
57,216
+4,512
| +9% | +$73K |
|
50
Biogen
BIIB
$30B
| $904K | 0.26% |
3,308
-35
| -1% | -$9.9K |
|
Similar funds
ARK Investment Management's Q1 2017 Portfolio in Review
As of Q1 2017, ARK Investment Management held 109 positions worth $347M, up 26% from $275M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
ARK Investment Management deployed $23.1M of net new capital in Q1 2017, opening 7 new positions and adding to 73 existing holdings. Its largest new stake was Editas Medicine: 229,922 shares worth $5.13M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Illumina, an estimated $5.87M trimmed.
- ARK Investment Management's largest Q1 2017 buy was Editas Medicine: 229,922 shares worth $5.13M.
- ARK Investment Management added most to Ionis Pharmaceuticals in Q1 2017, an estimated $5.43M increase.
- ARK Investment Management's biggest Q1 2017 reduction was Illumina, cutting an estimated $5.87M.
- ARK Investment Management fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $512K.
- ARK Investment Management's ten largest holdings make up 44% of its $347M portfolio in Q1 2017.
- ARK Investment Management opened 7 new positions and closed 5 in Q1 2017.
- ARK Investment Management's portfolio value rose 26% quarter-over-quarter to $347M.
Based on ARK Investment Management's 13F filing for Q1 2017, filed 15 May 2017.